PharmaNet/i3
PharmaNet/i3, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, PharmaNet/i3 works for you.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
From Booth to Bavaria: A Recap of Impact at ESC 2026
Press Releases | September 7, 2026 | Medscape Education
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based...
Supporting the people who support patients
Press Releases | August 28, 2026 | Mednet
Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.
NEW PHARMA-EXCLUSIVE WEBINAR: Beyond the Hype; Practical, Compliant AI Solutions for Pharma Engagement
Press Releases | August 27, 2026 | Impetus Digital
See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards
Intelligent Commercialization™ across the pharma lifecycle
White Papers and Resources | August 27, 2026 | Inizio
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
White Papers and Resources | August 27, 2026 | Inizio
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.
Real Chemistry Deepens German Market Expertise with Appointment of Dirk Poschenrieder as Managing Director, Germany
Press Releases | August 25, 2026 | Real Chemistry
Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution
Cutting the friction from health comms through whole-person design
Press Releases | August 24, 2026 | Mednet
Good design can’t change the reality of illness, remove the pain, or stop the uncertainty. But it can stop learning what comes next from being another burden to carry.
The Future of Decisioning
Press Releases | August 20, 2026 | Havas Lynx
The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising,...
Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth
Press Releases | August 19, 2026 | Lucid Group Communications Limited
Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board
Treating phase 2 study design as a scientific decision is compromising launch performance, warns expert
Press Releases | August 17, 2026 | Nmblr
17th August 2026 – Treating Phase 2 study design solely as a set of scientific decisions, without commercial input, is compromising launch performance, according to Janice MacLennan, founder of Nmblr,...